Published in Cancer Weekly, October 21st, 2003
According to recent research published in the journal Cancer Research, "The c-myc oncogene is commonly activated in medulloblastoma.
"Genomic amplification is a well-documented cause of c-myc activation but does not account for all cases of c-myc activation. In this study, we sought other means by which c-myc is overexpressed in medulloblastoma," wrote I.M. Siu and colleagues, Duke University Medical Center.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.